Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 4

Tempus AI, Inc.

TEMNASDAQEQUITYCurrent

SEC Filing

Filed Aug 27, 2026Accepted Aug 27, 2026, 8:27 PM EDTCIK 1717115Accession 0001114357-26-000034
Share

Company context

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.

Current securities

Recent company filings

  1. 4 filingSep 24, 2026
  2. 4 filingSep 18, 2026
  3. 144 filingSep 17, 2026
  4. 425 filingSep 15, 2026
  5. 4 filingSep 3, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗